{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T11:40:29Z","timestamp":1786362029729,"version":"build-2736575974"},"reference-count":17,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","redjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1016\/j.ijrobp.2018.01.008","type":"journal-article","created":{"date-parts":[[2018,1,9]],"date-time":"2018-01-09T15:18:26Z","timestamp":1515511106000},"page":"1204-1209","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"title":["Radiation Therapy to Sites of Metastatic Disease as Part of Consolidation in High-Risk Neuroblastoma: Can Long-term Control Be Achieved?"],"prefix":"10.1016","volume":"100","author":[{"given":"Dana L.","family":"Casey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken L.","family":"Pitter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian H.","family":"Kushner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nai-Kong V.","family":"Cheung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shakeel","family":"Modak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael P.","family":"LaQuaglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne L.","family":"Wolden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2018.01.008_bib1","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.ijrobp.2016.05.020","article-title":"Local control with 21-Gy radiation therapy for high-risk neuroblastoma","volume":"96","author":"Casey","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2018.01.008_bib2","doi-asserted-by":"crossref","first-page":"2821","DOI":"10.1200\/JCO.2001.19.11.2821","article-title":"Hyperfractionated low-dose radiotherapy for high-risk neuroblastoma after intensive chemotherapy and surgery","volume":"19","author":"Kushner","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2018.01.008_bib3","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1016\/j.ijrobp.2008.10.069","article-title":"Excellent local control from radiation therapy for high-risk neuroblastoma","volume":"74","author":"Gatcombe","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2018.01.008_bib4","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1002\/cncr.20091","article-title":"Fractionated low-dose radiotherapy after myeloablative stem cell transplantation for local control in patients with high-risk neuroblastoma","volume":"100","author":"Bradfield","year":"2004","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2018.01.008_bib5","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.ijrobp.2014.04.004","article-title":"Likelihood of bone recurrence in prior sites of metastasis in patients with high-risk neuroblastoma","volume":"89","author":"Polishchuk","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2018.01.008_bib6","doi-asserted-by":"crossref","first-page":"4888","DOI":"10.1200\/JCO.2004.02.101","article-title":"Reduction from seven to five cycles of intensive induction chemotherapy in children with high-risk neuroblastoma","volume":"22","author":"Kushner","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2018.01.008_bib7","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1002\/pbc.21384","article-title":"Brain-sparing radiotherapy for neuroblastoma skull metastases","volume":"50","author":"Wolden","year":"2008","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.ijrobp.2018.01.008_bib8","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1016\/j.ijrobp.2008.12.026","article-title":"Hyperfractionated low-dose (21 Gy) radiotherapy for cranial skeletal metastases in patients with high-risk neuroblastoma","volume":"75","author":"Kushner","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2018.01.008_bib9","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/0360-3016(95)00011-M","article-title":"Patterns of failure following total body irradiation and bone marrow transplantation with or without a radiotherapy boost for advanced neuroblastoma","volume":"32","author":"Sibley","year":"1995","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2018.01.008_bib10","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1080\/08880010390158504","article-title":"Relapse in the skull after myeloablative therapy for high-risk neuroblastoma","volume":"20","author":"Sangthawan","year":"2003","journal-title":"Pediatr Hematol Oncol"},{"key":"10.1016\/j.ijrobp.2018.01.008_bib11","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.jpedsurg.2003.11.028","article-title":"The impact of gross total resection on local control and survival in high-risk neuroblastoma","volume":"39","author":"La Quaglia","year":"2004","journal-title":"J Pediatr Surg"},{"key":"10.1016\/j.ijrobp.2018.01.008_bib12","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s00066-006-1498-8","article-title":"Intensified external-beam radiation therapy improves the outcome of stage 4 neuroblastoma in children >1 year with residual local disease","volume":"182","author":"Simon","year":"2006","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.ijrobp.2018.01.008_bib13","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/S0360-3016(02)04506-6","article-title":"Impact of radiotherapy for high-risk neuroblastoma: A Children's Cancer Group study","volume":"56","author":"Haas-Kogan","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2018.01.008_bib14","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1016\/j.ijrobp.2014.07.019","article-title":"Radiation therapy to the primary and postinduction chemotherapy MIBG-avid sites in high-risk neuroblastoma","volume":"90","author":"Mazloom","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2018.01.008_bib15","first-page":"395","article-title":"Monoclonal antibody 3F8 can effect durable remissions in neuroblastoma patients refractory to chemotherapy: A phase II trial","volume":"366","author":"Cheung","year":"1991","journal-title":"Prog Clin Biol Res"},{"key":"10.1016\/j.ijrobp.2018.01.008_bib16","first-page":"595","article-title":"Iodine 131 labeled GD2 monoclonal antibody in the diagnosis and therapy of human neuroblastoma","volume":"271","author":"Cheung","year":"1988","journal-title":"Prog Clin Biol Res"},{"key":"10.1016\/j.ijrobp.2018.01.008_bib17","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1200\/JCO.1998.16.1.229","article-title":"Phase I dose escalation of 131I-metaiodobenzylguanidine with autologous bone marrow support in refractory neuroblastoma","volume":"16","author":"Matthay","year":"1998","journal-title":"J Clin Oncol"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301618300087?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301618300087?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T09:42:21Z","timestamp":1759743741000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0360301618300087"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":17,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,4]]}},"alternative-id":["S0360301618300087"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2018.01.008","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2018,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Radiation Therapy to Sites of Metastatic Disease as Part of Consolidation in High-Risk Neuroblastoma: Can Long-term Control Be Achieved?","name":"articletitle","label":"Article Title"},{"value":"International Journal of Radiation Oncology*Biology*Physics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijrobp.2018.01.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}